Human VEGF-C ELISA Kit (FM-E100164)
search
  • Human VEGF-C ELISA Kit (FM-E100164)

Human VEGF-C ELISA Kit

Catalog # FM-E100164

Print

$625.00
Quantity

For research use only. Not for diagnostic or therapeutic use, or for human or veterinary use. Sold only to research institutions and qualified laboratory professionals. Not for sale to individuals for personal use.

Assay Range

62.5--4000 pg/mL

Sensitivity

3.0 pg/mL

Size

96T

Storage

Store at 2 - 8ºC. Keep reconstituted standard and detection Ab at -20 ºC

Assay Principle

Sandwich ELISA

Sample volume

100 µL final volume, dilution factor varies on samples

Detection Method

Chromogenic

 

 

Kit Components

 

 1. RecombinantHuman VEGF-C standard: 2 vials

 2. One 96-well plate precoated with anti-Human VEGF-C Ab

 3. Sample diluent buffer: 12 mL - 1

 4. Detection antibody: 130 µL, dilution 1:100

 5. Streptavidin-HRP: 130 µL, dilution 1:100

 6. Antibody diluent buffer: 12 mL x1   

 7. Streptavidin-HRP diluent buffer: 12 mL x1

 8. TMB developing agent: 10 mL x1

9. Stop solution: 10 mL x1.

10. Washing solution (20x): 25 mL x1.

 

 

Background

 

The Vascular Endothelial Growth Factors (VEGFs) including VEGF-A, -B, -C, -D, -E and Placenta Growth Factor (PlGF), play important roles in vascular and lymphatic vessel growth. VEGF-C, also known as Flt4 ligand (Flt4-L), or vascular endothelial growth factor-related protein (VRP), has the conserved VEGF homology domain (VHD) and is characteristic of long N- and C-terminal extensions. VEGF-C is expressed primarily in lymph nodes, heart, placenta, ovary, and small intestine. VEGF-C binds and activates VEGF R2 and VEGF R3 to transduce its signals in the target cells. It has been shown that a number of proteolytically processed VEGF-C isoforms can bind VEGF R3 with different affinity, only the mature VEGF-C can bind VEGF R2. The Integrin α9β1 and the Semaphorin/VEGF family receptor Neuropilin-2 may also act as receptors or co-receptors for VEGF-C. VEGF-C induces vascular permeability through the activation of VEGF R2. VEGF-C and VEGF R3 are co-expressed at sites of lymphatic vessel sprouting in the embryo, the VEGF-C/VEGF R3 signaling pathway is crucial to lymphangiogenesis. Elevated VEGF-C levels have been correlated with many human cancers. Increased VEGF-C-mediated lymphangiogenesis and metastases are observed in several models of human cancer, suggesting that overexpression of VEGF-C might be a predictor of lymph node metastases.

New